Investment Rating - The report gives a "Buy" rating for the company, marking its first coverage [7]. Core Views - The company is positioned at the bottom of the pesticide industry cycle, leveraging its integrated production chain based on phosgene to explore new opportunities [4]. - The overall pesticide prices are at a relatively low point, with expectations for recovery to enhance profitability [7]. - The company has a robust cash flow, which supports the upgrading of its industrial chain and optimizes costs [7]. Summary by Sections 1. Complete Industrial Chain Supports Rapid Development - The company is one of the largest domestic producers of pesticide raw materials and intermediates based on phosgene, forming a complete industrial chain from raw materials to intermediates to agricultural products [12]. - The company has a stable shareholding structure, with the actual controllers holding a high concentration of shares, which is beneficial for long-term development [17]. - The company has ample funds, with a total of 8.685 billion yuan in cash and other liquid assets by 2024, providing sufficient financial support for long-term construction and development [23]. 2. Steady Development of the Pesticide Sector - The pesticide sector is experiencing price recovery from a low point, which is expected to enhance profits [7]. - The company is a leading producer of the fungicides carbendazim and methyl thiophanate, with significant production capacity [32]. - The company is among the first in China to achieve production of the herbicide dicamba, holding a leading position in domestic production capacity [45]. 3. Leveraging Phosgene Resources for Industrial Chain Expansion - The company is a leader in the phosgene-based pesticide industry, with a high entry barrier for phosgene production [7]. - Phosgene resources are scarce, and the company has a diverse range of downstream products [7]. - Phosgene can be used to produce isocyanates, which have excellent performance in modified products, providing new directions for industrial development [7]. 4. Profit Forecast and Valuation - The company is expected to achieve total revenue of 50.21 billion yuan, 54.49 billion yuan, and 59.67 billion yuan from 2025 to 2027, with year-on-year growth rates of 8.15%, 8.52%, and 9.51% respectively [7]. - The net profit attributable to shareholders is projected to be 9.39 billion yuan, 11.18 billion yuan, and 12.26 billion yuan for the same period, with growth rates of 20.59%, 19.07%, and 9.62% respectively [7]. - The earnings per share (EPS) are expected to be 1.03 yuan, 1.23 yuan, and 1.35 yuan, corresponding to price-to-earnings (P/E) ratios of 11.17, 9.38, and 8.55 [7].